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Hutchinson-Gilford progeria (HGPS) is
a rare, genetic progeroid disorder that
causes premature ageing, nuclear lam-
ina shape abnormalities, growth impair-
ment, and early death at ∼13 year of age
(Gordon et al., 2013). The disorder is a
result of a spontaneous point mutation
in the gene lamin A/C (LMNA) which
encodes for the nuclear lamina scaffold
protein, prelamin A. The most common
point mutation occurs within exon 11 and
results in a silent Gly-to-Gly mutation
that causes increased usage of an inter-
nal cryptic splice site. This cryptic splice
site produces a truncated form of prelamin
A known as progerin (Eriksson et al.,
2003). In non-mutated cells, prelamin A
undergoes a series of modifications to
produce lamin A, a vital nuclear lamina
structural protein. Prelamin A contains a
carboxyterminal CAAX motif that is far-
nesylated on the CAAX motif cysteine by
farnesyltransferase (FTase). Farnesylation
then targets prelamin A to the inner
nuclear membrane where the last three
amino acids are cleaved by zinc met-
allopeptidase STE24 (ZMPSTE24). This
is followed by immediate methylation of
the farnesylcysteine by isoprenylcysteine
carboxyl methyltransferase (ICMT) and
subsequent cleavage by ZMPSTE24 to pro-
duce lamin A. Following cleavage from the
nuclear membrane, lamin A is capable of
migrating to the nucleoplasm. In HGPS,
progerin lacks a vital cleavage site utilized
by ZMPSTE24. This results in progerin
remaining permanently attached to the
inner nuclear membrane and is suspected
to contribute the HGPS phenotype (Fantle
et al., 1994; Davies et al., 2009).
Although previous studies have been
dedicated to treating HGPS by halting far-
nesylation via FTase inhibitors, Ibrahim
et al. targeted Icmt expression as a means
to reverse progeria-like symptoms in a
mouse model of HGPS (Ibrahim et al.,
2013). Methylation of other CAAX pro-
tein motifs has been shown to play a
role in protein membrane targeting (Bergo
et al., 2002; Michaelson et al., 2005). To
explore the role of CAAX methylation
in HGPS, Ibrahim et al. introduced a
hypomorphic allele of Icmt into a mouse
model of HGPS that utilizes Zmpste24
deficient mice. It was found that the
mice hypomorphic for Icmt had increased
body weight, normalized grip strength,
decreased bone fractures and decreased
death compared to non-hypomorphic
mice.
Analysis of primary mouse embry-
onic fibroblasts obtained from sacrificed
mice indicate that reduced ICMT activity
does not affect levels of prelamin A, but
instead causes mislocalization of prelamin
A away from the nuclear rim. Interestingly,
there is not a subsequent reduction in the
number of misshapen nuclei in Icmt hypo-
morphic mice fibroblasts. This indicates
that misshapen nuclei play a lesser role
in the HGPS phenotype than previously
thought. Icmt hypomorphic mice fibrob-
lasts also restored cell proliferation to rates
similar to wild type fibroblasts. To fur-
ther elucidate the role of ICMT within cell
proliferation, Ibrahim et al. evaluated the
impact of ICMT on the on AKT-mTOR
cell growth, proliferation and survival
pathway. It was found that reduced ICMT
activity triggers prelamin A dependent
activation of AKT-mTOR, which decreases
premature senescence of Zmpste24
deficient fibroblasts. Furthermore, ICMT
activates the pathway through AKT and
not mTOR. The precise mechanism of
interaction was not determined.
The findings of the Ibrahim et al. study
are interesting not only to the field of
progeroid disorders, but to the field of age-
ing studies at large. Scaffidi and Misteli
found that dermal fibroblasts with wild
type LMNA are capable of utilizing the
cryptic spice site seen in HGPS cells. The
truncated protein was not found to accu-
mulate with age, but the localization of
the protein shifted from the nucleoplasm
to the nuclear rim with increasing age
(Scaffidi and Misteli, 2006). Other stud-
ies have found mixed results with some
reporting a direct correlation between
progerin accumulation and age and oth-
ers finding no association (McClintock
et al., 2007; Cao et al., 2011). Progerin
accumulation has also been linked to
telomere dysfunction in normal human
fibroblasts. Cells utilizing the LMNA cryp-
tic splice site have shorter telomeres and
high senescence-associated β-gal activity
(Cao et al., 2011).
Thus, the LMNA splice site plays a
critical role not only in HGPS but also
in normal ageing and cellular senes-
cence. The Ibrahim et al. study has
provided promising results for prevent-
ing progerin accumulation at the nuclear
rim by reducing ICMT activity. Finding
endogenous and exogenous mediators
that can control the ICMT activity seen
in aging conditions is an important
step to discover pharmaceutical inter-
vention and even possible reverse aging.
Understanding the influence of ICMT
in aging is likely to provide important
insights that will not only guide investi-
gation of the molecular and cellular basis
of aging, but may also help to identify
novel treatment strategies targeting these
pathways.
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